High Drug Prices: How We Got Here and How We Achieve Affordability

The current state of the pharmacy system is challenged by rising list prices, the affordability of new brand and specialty products coming to market, and intermediaries whose interests are not always aligned with their clients. The blame lies across a variety of players. The problem is complex, which creates confusion among lawmakers, regulators, and the public, with a resolution to this issue seeming elusive.

Read the source article at Pharmacy Times
2021-12-02 20:21:00